Schedule 13G ownership disclosure

N/A

Security class unavailable · CUSIP: 01345P106

Event date: 2022-03-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
971,885
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001740053-22-000004
Form type
SC 13G
Filer
ALBIREO PHARMA, INC.
CIK
CIK 1322505
Filed
Mar 07, 2022
Reporting period
Mar 01, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub